Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

MONOGRAM BIOSCIENCES, INC. - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 17
ISBN Number not applicable
Product Code GMD02167

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Monogram Biosciences, Inc. - Financial and Strategic Analysis Review

Monogram Biosciences, Inc. (Monogram) is a life sciences company engaged in developing and commercializing innovative products that help, guide and improve the treatment of infectious diseases, cancer and other serious diseases in the United States. Its products for HIV testing, including GeneSeq HIV, PhenoSense HIV Entry, and PhenoSense HIV Integrase, Geneseq HIV, Geneseq HIV Entry. The company is head quartered in California, United States.

Global Markets Direct's Monogram Biosciences, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Monogram Biosciences, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • History
    • SWOT Analysis
    • SWOT Analysis - Overview
    • Monogram Biosciences, Inc. - Strengths
    • Monogram Biosciences, Inc. - Strengths - Market Leadership in HIV Drug Resistance Testing
    • Monogram Biosciences, Inc. - Strengths - Sturdy Research and Development Activities
    • Monogram Biosciences, Inc. - Weaknesses
    • Monogram Biosciences, Inc. - Weaknesses - Losses from Operations
    • Monogram Biosciences, Inc. - Opportunities
    • Monogram Biosciences, Inc. - Opportunities - Tropism Patient Selection Test
    • Monogram Biosciences, Inc. - Opportunities - Launch of HERmark
    • Monogram Biosciences, Inc. - Opportunities - Focus on Growing Therapeutic Segments
    • Monogram Biosciences, Inc. - Opportunities - Emerging Markets
    • Monogram Biosciences, Inc. - Opportunities - Changing Demographics
    • Monogram Biosciences, Inc. - Opportunities - Rising Healthcare Expenditure in the US
    • Monogram Biosciences, Inc. - Threats
    • Monogram Biosciences, Inc. - Threats - Intense Competition
    • Monogram Biosciences, Inc. - Threats - Changing Political Climate in the US
    • Monogram Biosciences, Inc. - Threats - Impact of Financial Crisis
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Locations And Subsidiaries
    • Locations And Subsidiaries - Head Office
    • Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Monogram Biosciences, Inc., Key Facts
    • Major Products and Services
    • Monogram Biosciences, Inc., History
    • Monogram Biosciences, Inc., Key Employees
    • Monogram Biosciences, Inc., Key Employee Biographies
    • Monogram Biosciences, Inc., Ratios based on current share price
    • Monogram Biosciences, Inc., Annual Ratios
    • Monogram Biosciences, Inc., Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • Monogram Biosciences, Inc., Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis